Cartia XT — Class III drug recall D-0488-2015
Terminated recall by Actavis Laboratories, FL, Inc., reported 2015-04-22, distributed nationwide. Presence of Foreign Substance; fine residue or dust identified as aluminum may be on exterior of the capsule s
| Recall number | D-0488-2015 |
|---|---|
| Product type | Drug |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Actavis Laboratories, FL, Inc., Davie, FL, United States |
| Recall initiated | 2015-03-26 |
| Classified | 2015-04-15 |
| Reported by FDA | 2015-04-22 |
| Terminated | 2016-12-30 |
| Distributed | Nationwide (US) |
| Quantity | 2,628 bottles |
| NDC | 62037-0600-90 |
| Lot numbers | 956000M |
| Expiration dates | 2016-08-20 |
Product
Cartia XT (diltiazem HCl extended-release capsules, USP), Once-A-Day Dosage, 300 mg, 90-count bottles, Rx only, Manufactured by: Watson Laboratories, Inc., Corona, CA --- NDC 62037-0600-90
Reason for recall
Presence of Foreign Substance; fine residue or dust identified as aluminum may be on exterior of the capsule shell
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0488-2015. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.